Skip to main content

Seagen Inc.

SGENDelisted Dec 14, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001060736

Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Seagen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Seagen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Seagen Inc.
NameTitleLast reported holdingLast filingFilings, past year
Baker JulianDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker FelixDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Bros. Advisors LPDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Brothers Life Sciences LPDirector, Other: Former 10% Owner0IndirectDec 18, 20230
667, L.P.Director, Other: Former 10% Owner0IndirectDec 18, 20230
Baker Bros. Advisors (GP) LLCDirector, Other: Former 10% Owner0IndirectDec 18, 20230
Love Ted WDirector0Dec 15, 20230
Gryska David WDirector0Dec 15, 20230
Welch Daniel GDirector0IndirectDec 15, 20230
Simpson Todd EChief Financial Officer0Dec 15, 20230
Liu Jean IChief Legal Officer0Dec 15, 20230
Simonian Nancy ADirector0Dec 15, 20230
Himes Vaughn BChief Technical Officer0IndirectDec 15, 20230
Epstein David RCEO0Dec 15, 20230
Orwin John ADirector0Dec 15, 20230
Seth AlpnaDirector0Dec 15, 20230
Dansey Roger DPresident, R&D & CMO0Dec 15, 20230
Romp Charles REVP, Commercial U.S.0Dec 15, 20230
Swain Sandra MDirector0Dec 15, 20230
Siegall Clay BPresident & CEO666,060May 13, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 26, 2023 (view filing)Jan 242 daysLiu Jean IChief Legal OfficerSSale−5.00K$135.03−$675.1K−5.5%85.1K after
Jan 19, 2023 (view filing)Jan 172 daysLiu Jean IChief Legal OfficerSSale−578$130.71−$75.6K−0.7%85.1K after
Jan 6, 2023 (view filing)Jan 4-52 daysDansey Roger DPresident R&D & CMOSSale−10.0K$135.00−$1.35M−9.3%97.5K after2 lots
Jan 6, 2023 (view filing)Jan 4-52 daysLiu Jean IChief Legal OfficerSSale−5.00K$135.00−$675.0K−5.5%85.7K after2 lots
Dec 21, 2022 (view filing)Dec 201 dayRomp Charles REVP, Commercial U.S.SSale−1.13K$127.63−$144.1K−1.9%58.5K after
Dec 16, 2022 (view filing)Dec 142 daysDansey Roger DPresident, Research and DeveloSSale−10.0K$135.00−$1.35M−9.3%97.5K after2 lots
Nov 18, 2022 (view filing)Nov 171 dayLiu Jean IChief Legal OfficerSSale−8.33K$131.05−$1.09M−8.9%85.7K after
Nov 15, 2022 (view filing)Nov 114 daysGryska David WDirectorSSale−7.50K$129.10−$968.3K−15.7%40.3K after
Oct 19, 2022 (view filing)Oct 172 daysDansey Roger DInterim CEO & CMOSSale−10.0K$135.00−$1.35M−9.3%97.5K after3 lots
Sep 1, 2022 (view filing)Aug 311 daySimpson Todd EChief Financial OfficerSSale−4.19K$154.41−$646.4K−3.0%137.2K after2 lots
Sep 1, 2022 (view filing)Aug 311 dayHimes Vaughn BChief Technical OfficerSSale−3.58K$154.41−$553.4K−5.1%67.2K after2 lots
Sep 1, 2022 (view filing)Aug 311 dayRomp Charles REVP, CommercialSSale−1.13K$154.41−$174.9K−1.9%59.6K after2 lots
Sep 1, 2022 (view filing)Aug 311 dayDansey Roger DInterim CEO & CMOSSale−5.02K$154.41−$775.0K−4.9%97.5K after3 lots
Sep 1, 2022 (view filing)Aug 311 dayLiu Jean IChief Legal OfficerSSale−3.65K$154.41−$563.3K−4.1%84.4K after2 lots
Aug 17, 2022 (view filing)Aug 161 daySimpson Todd EChief Financial OfficerSSale−1.97K$170.22−$334.8K−1.4%141.4K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayRomp Charles REVP, CommercialSSale−1.76K$170.22−$300.4K−2.8%60.7K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayLiu Jean IChief Legal OfficerSSale−1.64K$170.22−$279.0K−1.8%88.0K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayHimes Vaughn BChief Technical OfficerSSale−1.53K$170.22−$259.9K−2.1%70.8K after2 lots
Aug 17, 2022 (view filing)Aug 161 dayDansey Roger DInterim CEO & CMOSSale−4.25K$170.22−$724.1K−4.0%102.6K after2 lots
Jul 7, 2022 (view filing)Jul 52 daysRomp Charles REVP, CommercialSSale−712$179.46−$127.8K−1.4%48.8K after
Jun 30, 2022 (view filing)Jun 282 daysDansey Roger DChief Medical OfficerSSale−34.6K$180.00−$6.23M−35.8%62.1K after5 lots
Jun 22, 2022 (view filing)Jun 175 daysHimes Vaughn BChief Technical OfficerSSale−1.13K$160.00−$181.4K−0.9%119.5K after
May 26, 2022 (view filing)May 242 daysHimes Vaughn BChief Technical OfficerSSale−10.9K$136.79−$1.49M−15.5%59.1K after3 lots
May 18, 2022 (view filing)May 162 daysRomp Charles REVP, CommercialSSale−333$134.21−$44.7K−0.7%49.5K after
May 13, 2022 (view filing)May 121 daySiegall Clay BPresident & CEOSSale−17.0K$125.69−$2.14M−2.5%666.1K after2 lots
Apr 22, 2022 (view filing)Apr 202 daysSiegall Clay BPresident & CEOSSale−1.89K$144.32−$272.0K−0.3%666.1K after
Apr 22, 2022 (view filing)Apr 202 daysSimpson Todd EChief Financial OfficerSSale−567$144.32−$81.8K−0.4%127.9K after
Apr 22, 2022 (view filing)Apr 202 daysLiu Jean IChief Legal OfficerSSale−401$144.32−$57.9K−0.5%75.9K after
Apr 22, 2022 (view filing)Apr 202 daysRomp Charles REVP, CommercialSSale−319$144.32−$46.0K−0.6%49.8K after
Apr 22, 2022 (view filing)Apr 202 daysHimes Vaughn BChief Technical OfficerSSale−574$144.32−$82.8K−1.0%59.1K after
Apr 22, 2022 (view filing)Apr 20-212 daysDansey Roger DChief Medical OfficerSSale−1.44K$144.24−$207.6K−1.8%77.0K after2 lots
Apr 21, 2022 (view filing)Apr 192 daysGryska David WDirectorSSale−4.00K$143.95−$575.8K−8.0%46.3K after3 lots
Apr 8, 2022 (view filing)Apr 71 daySiegall Clay BPresident and CEOSSale−17.0K$154.23−$2.63M−2.5%667.9K after7 lots
Mar 9, 2022 (view filing)Mar 72 daysSiegall Clay BPresident & CEOSSale−17.0K$134.35−$2.29M−2.5%667.9K after5 lots
Mar 4, 2022 (view filing)Mar 31 dayHimes Vaughn BChief Technical OfficerSSale−12.0K$127.05−$1.52M−16.8%59.5K after2 lots
Feb 9, 2022 (view filing)Feb 72 daysSiegall Clay BPresident & CEOSSale−17.0K$139.97−$2.39M−2.5%667.9K after5 lots
Feb 9, 2022 (view filing)Feb 72 daysGryska David WDirectorSSale−4.50K$138.76−$624.4K−8.9%46.3K after3 lots
Feb 4, 2022 (view filing)Feb 2-32 daysDansey Roger DChief Medical OfficerSSale−1.44K$136.88−$197.4K−1.8%78.2K after2 lots
Feb 1, 2022 (view filing)Jan 284 daysGryska David WDirectorSSale−4.50K$122.56−$551.5K−8.9%46.3K after4 lots
Jan 19, 2022 (view filing)Jan 145 daysGryska David WDirectorSSale−4.50K$135.24−$608.6K−8.9%46.3K after
Jan 11, 2022 (view filing)Jan 74 daysSiegall Clay BPresident & CEOSSale−17.0K$144.73−$2.47M−2.5%667.9K after4 lots
Jan 5, 2022 (view filing)Jan 32 daysDansey Roger DChief Medical OfficerSSale−8.68K$152.58−$1.32M−9.8%79.7K after3 lots
Dec 22, 2021 (view filing)Dec 202 daysRomp Charles REVP, CommercialSSale−1.32K$149.85−$198.3K−2.6%50.0K after2 lots
Dec 22, 2021 (view filing)Dec 202 daysHimes Vaughn BChief Technical OfficerSSale−345$149.85−$51.7K−0.6%59.5K after
Dec 22, 2021 (view filing)Dec 20-212 daysDansey Roger DChief Medical OfficerSSale−560$152.72−$85.5K−0.6%88.4K after2 lots
Dec 22, 2021 (view filing)Dec 202 daysSiegall Clay BPresident & CEOSSale−1.23K$149.85−$183.9K−0.2%667.9K after
Dec 22, 2021 (view filing)Dec 202 daysSimpson Todd EChief Financial OfficerSSale−345$149.85−$51.7K−0.3%128.5K after
Dec 22, 2021 (view filing)Dec 202 daysLiu Jean IChief Legal OfficerSSale−276$149.85−$41.4K−0.4%70.4K after
Dec 9, 2021 (view filing)Dec 72 daysSiegall Clay BPresident & CEOSSale−45.4K$148.66−$6.76M−6.4%669.2K after5 lots
Dec 2, 2021 (view filing)6:51 PM ETNov 30-Dec 12 daysBaker Julian and 5 othersDirector, 10% OwnerSSale−394.9K$160.54−$63.4M−0.9%42.9M after20 lots